Optum Logo

Healthcare professionals working in organisations that use Optum ScriptSwitch™ can now access publications from Keele’s Important News and Evidence Service (KINES). Please visit the Registration page to request access. Optum ScriptSwitch™ Users – if you have previously requested access please ensure you are logged in to view these publications.

Publications include:

  • KINES Rapid Updates – concise summaries of new evidence or developments that relate to prescribing in primary care.
  • KINES Monthly News Updates – summary of developments at key organisations (e.g. NICE, MHRA, NHS England , etc.), plus a drug update and other news relating to prescribing in primary care.  NEW Nov-17: From November 2017, a ‘Scotland edition‘ of this monthly newsletter is also available.

How to find publications: 

  • All KINES publications issued to date are listed below.
  • Users can also use the search box above to look for content, e.g. by disease or drug name. Searching will also return National Prescribing Centre (NPC) archive materials, which have also been uploaded to this website. These NPC materials have not been updated since their publication but may contain some useful information.
  • Content has also been classified under the various categories on the right hand side – e.g. hypertension; polypharmacy; etc

Disclaimer: Information correct at time of publication. The views expressed are Keele’s and may not reflect local prescribing guidance. External hyperlinks are provided as a convenience but are out of Keele’s control and do not constitute an endorsement by Keele.

KINES publications:




Publications prior to October 2016:

All content displayed and/or linked to on this webpage that is dated prior to October 2016 (the “Content”) was produced by Keele University independent of Optum and pre-dates Optum’s partnership with The Centre for Medicines Optimisation at Keele University. Any and all views expressed in the Content are solely that of Keele University. In no event shall Optum be liable for any damages whatsoever arising out of the completeness, correctness, accuracy, or currentness of, content of (or omissions from), use of, reliance on, inability to use, or the resulting use of the Content, whether based on contract, tort, or any other legal theory.